top of page
shutterstock_102423982_edited.jpg
Logo Oftacreations

A new horizon in vitreoretinal surgery

OftaCreations is a pioneering vitreoretinal surgery company. We are specialized in the research and development of surgical solutions for vitreoretinal diseases. OftaCreations is founded by highly experienced professionals with a long and successful track record. We strive to empower vitreoretinal surgeons to enable safer and more effective surgical interventions. We focus on innovation and precision, with advanced tools and techniques.

what

Open for new product ideas from surgeons and surgical industry

how

OftaCreations leads the initial stage-gate development of innovative product ideas, from concept creation to a proof of principle, along with an initial feasibility study. After successful completion of the concept phase an industry partner will be sourced for further product development like detailed design, verification and validation process, the certification, production phase and market introduction.

Together with top surgeons

OftaCreations works in close relationship with top surgeons worldwide. Together, we harness expertise and leverage synergies. We accelerate the translation of scientific discoveries into clinically impactful innovations. Solutions, that advance the standard of care in vitreoretinal surgery.

Clients

Your research partner in new product development

OftaCreations is founded by Ger Vijfvinkel and Frank Ruseler

ger_IMG_7012_bewerkt_RGB_edited.jpg

Ger Vijfvinkel has led over 45 years of innovations in ophthalmic surgical techniques, instruments and equipment, which are still a standard in today’s surgical procedures.

Ger was founder and president of DORC from 1983 till 2009 and DORC Board Advisor on R&D and market development (2009-2013). He founded Oftavinci Research and was its CEO from 2013 till 2017. At Vitreq, he was research advisor for Vitreq from 2017 until 2022.

frank_IMG_7019_bewerkt_RGB_edited.jpg

Frank Ruseler has over 30 years of experience in the worldwide marketing & sales, worldwide KOL and general management and new business development in the ophthalmic surgical medical device

industry. Frank drives surgical ophthalmic innovations from product ideas to final commercial products,

including worldwide market introductions. He joined DORC in 1993 and has been DORC’s Global Business Development Director until 2014. Frank co-founded Vitreq and was CEO from 2014 till 2022.

bottom of page